193 related articles for article (PubMed ID: 28578978)
1. Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study.
Tai CS; Wu JF; Chen HL; Hsu HY; Chang MH; Ni YH
J Formos Med Assoc; 2018 May; 117(5):421-426. PubMed ID: 28578978
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
3. Wilson disease.
El-Youssef M
Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
[TBL] [Abstract][Full Text] [Related]
4. Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.
Seessle J; Gotthardt DN; Schäfer M; Gohdes A; Pfeiffenberger J; Ferenci P; Stremmel W; Weiss KH
J Inherit Metab Dis; 2016 Jan; 39(1):125-30. PubMed ID: 26067812
[TBL] [Abstract][Full Text] [Related]
5. [Wilson disease].
Shimizu N
Nihon Rinsho; 2004 Jan; 62 Suppl():399-403. PubMed ID: 15011394
[No Abstract] [Full Text] [Related]
6. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
[TBL] [Abstract][Full Text] [Related]
7. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
8. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and care of Wilson disease with neurological revelation].
Wagner S; Brunet AS; Bost M; Lachaux A; Broussolle E; Des Portes V; Lion-François L
Arch Pediatr; 2012 Mar; 19(3):271-6. PubMed ID: 22261259
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease.
Wiggelinkhuizen M; Tilanus ME; Bollen CW; Houwen RH
Aliment Pharmacol Ther; 2009 May; 29(9):947-58. PubMed ID: 19210288
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective cross-sectional study based on nationwide data of drug prescriptions and contractional data of outpatient offices regarding Morbus Wilson's disease].
Janka SS; Bätzing J; Laux G; Holstiege J; Wahler S; Merle U; Mehrabi A; Mohr I; Weiss KH; Mieth M
Z Gastroenterol; 2020 Nov; 58(11):1054-1064. PubMed ID: 33197948
[TBL] [Abstract][Full Text] [Related]
12. Wilson Disease in Children.
Kerkar N; Rana A
Clin Liver Dis; 2022 Aug; 26(3):473-488. PubMed ID: 35868686
[TBL] [Abstract][Full Text] [Related]
13. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations.
Leung M; Wu Lanzafame J; Medici V
J Investig Med High Impact Case Rep; 2020; 8():2324709619896876. PubMed ID: 31920114
[No Abstract] [Full Text] [Related]
14. Characteristics and prevalence of Wilson's disease: A 2013 observational population-based study in France.
Poujois A; Woimant F; Samson S; Chaine P; Girardot-Tinant N; Tuppin P
Clin Res Hepatol Gastroenterol; 2018 Feb; 42(1):57-63. PubMed ID: 28648494
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database.
Dathe K; Beck E; Schaefer C
Reprod Toxicol; 2016 Oct; 65():39-45. PubMed ID: 27350316
[TBL] [Abstract][Full Text] [Related]
16. Wilson disease: clinical presentation, treatment, and survival.
Stremmel W; Meyerrose KW; Niederau C; Hefter H; Kreuzpaintner G; Strohmeyer G
Ann Intern Med; 1991 Nov; 115(9):720-6. PubMed ID: 1929042
[TBL] [Abstract][Full Text] [Related]
17. Wilson Disease: Diagnosis, Treatment, and Follow-up.
Schilsky ML
Clin Liver Dis; 2017 Nov; 21(4):755-767. PubMed ID: 28987261
[TBL] [Abstract][Full Text] [Related]
18. Population-based epidemiologic study of Wilson's disease in Taiwan.
Lai CH; Tseng HF
Eur J Neurol; 2010 Jun; 17(6):830-3. PubMed ID: 20100230
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
20. Neurological worsening in Wilson disease - clinical classification and outcome.
Mohr I; Pfeiffenberger J; Eker E; Merle U; Poujois A; Ala A; Weiss KH
J Hepatol; 2023 Aug; 79(2):321-328. PubMed ID: 37116715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
